KBC Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Sell |
2,941
-755
| -20% | -$27.5K | ﹤0.01% | 1161 |
|
|
2025
Q1 | $134K | Sell |
3,696
-57,314
| -94% | -$2.08M | ﹤0.01% | 1313 |
|
|
2024
Q4 | $2.57M | Buy |
61,010
+58,442
| +2,276% | +$2.46M | 0.01% | 648 |
|
|
2024
Q3 | $143K | Buy |
2,568
+506
| +25% | +$28.2K | ﹤0.01% | 1083 |
|
|
2024
Q2 | $85K | Buy |
2,062
+478
| +30% | +$19.7K | ﹤0.01% | 1266 |
|
|
2024
Q1 | $74K | Hold |
1,584
| – | – | ﹤0.01% | 1300 |
|
|
2023
Q4 | $76K | Hold |
1,584
| – | – | ﹤0.01% | 1237 |
|
|
2023
Q3 | $56K | Buy |
+1,584
| New | +$56K | ﹤0.01% | 1354 |
|